课题基金 / 基金详情

5th Cancer Cachexia Conference: Bridging Molecular Advances to Clinical Care

5th Cancer Cachexia Conference: Bridging Molecular Advances to Clinical Care
第五届癌症恶病质会议:将分子进展与临床护理联系起来
批准号:
412047
负责人:
Gallouzi Imed
金额:
$0.73万
依托单位:
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01

项目摘要

项目成果

Gallouzi Imed的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cachexia is a debilitating syndrome of cancer, characterized by severe weight loss resulting from the depletion of mainly skeletal muscle and adipose. Muscle atrophy in particular is associated with weakness and fatigue, a lower tolerance to chemotherapy,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mRNA Turnover: Mechanisms, Regulation and their Implication in Infectious and Age-Related Diseases
  • 批准号:
    404380
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2019
  • 负责人:
    Gallouzi Imed
  • 依托单位:
The role of the RNase G3BP1 in Senescence
  • 批准号:
    381621
  • 项目类别:
    Operating Grants
  • 资助金额:
    $59.35万
  • 财政年份:
    2018
  • 负责人:
    Gallouzi Imed
  • 依托单位:
Delineating the Mechanisms Underlying Nitric Oxide Induced Muscle Wasting During Cachexia
  • 批准号:
    381532
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.63万
  • 财政年份:
    2018
  • 负责人:
    Gallouzi Imed
  • 依托单位:
Elucidation of regulatory mechanisms modulating STAT3 expression during cancer-induced muscle atrophy
  • 批准号:
    321538
  • 项目类别:
    Operating Grants
  • 资助金额:
    $50.86万
  • 财政年份:
    2015
  • 负责人:
    Gallouzi Imed
  • 依托单位:
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2016
  • 负责人:
    金时
  • 依托单位: